Agonists of A1 and A(2A) adenosine receptors attenuate methamphetamine- induced overflow of dopamine in rat striatum

Brain Research

Volumn 806, Issue 2, 1998, Pages 202-209

  Gołembiowska, Krystyna ^a   Zylewska, Alicja ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Adenosine receptors; Dopamine release; In vivo microdialysis; Methamphetamine; Rat striatum

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR AGONIST; DOPAMINE; METHAMPHETAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; ADENOSINE; ADENOSINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; HOMOVANILLIC ACID; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ADMINISTRATION; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; OSMOLARITY; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ADENOSINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; HOMOVANILLIC ACID; MALE; METHAMPHETAMINE; MICRODIALYSIS; OSMOLAR CONCENTRATION; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1;

EID: 0032575776     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00743-4     Document Type: Article

References (45)

1. Alexander S.P., Reddington M. The cellular localization of adenosine receptors in rat neostriatum. Neuroscience. 28:1989;561-645.
2. 1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185:1995;29-32.
3. Borowsky B., Hoffman B.J. Neurotransmitter transporters: molecular biology function, and regulation. Int. Rev. Neurobiol. 38:1995;139-199.
4. Brunswick D.J., Benmansour S., Tejani-Butt S.M., Hauptmann M. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse. 11:1992;287-293.
5. Delle Donne K.T., Sonsalla P.K. Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. J. Pharmacol. Exp. Ther. 27:1994;1320-1326.
6. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J.S., Richardson P.J., Freeman T.C. Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol. 118:1996;1461-1468.
7. Ferré S., Fuxe K., von Euler G., Johansson B., Fredholm B.B. Adenosine-dopamine interactions in the rat brain. Neuroscience. 51:1992;501-512.
8. Ferré S., O'Connor W.T., Fuxe K., Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neuroscience. 13:1993;5402-5406.
9. 1 receptor-mediated mechanisms. Eur. J. Neurosci. 8:1996;1545-1553.
10. Fleckenstein A.E., Metzger R.R., Gibb J.W., Hanson G.R. A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur. J. Pharmacol. 323:1997;R9-R10.
11. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams A. VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
12. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:1988;130-134.
13. Fredholm B.B., Johansson B., van der Ploeg J., Hu P.S., Jin S. Neuromodulatory roles of purines. Drug Dev. Res. 28:1993;349-353.
14. Gibb J.W., Kogan F.J. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 310:1979;185-187.
15. 2A receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmacol. 323:1997;127-131.
16. Heffner T.G., Wiley J.N., Williams A.E., Bruns R.F., Conghenour L.L. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology. 98:1989;31-37.
17. Hirata H., Ladenheim B., Carlson E., Epstein Ch., Cadet J.L. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714:1996;95-103.
18. 2 receptors on striatal acetylcholine release in rats. Brain Res. Bull. 43:1997;107-115.
19. Imperato A., Di Chiara G. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neuroscience. 4:1984;966-977.
20. Ishii H., Stanimirovic D.B., Chang C.J., Mrsulja B.B., Spatz M. Dopamine metabolism and free-radical related mitochondrial injury during transient brain ischemia in gerbils. Neurochem. Res. 18:1993;1193-1201.
21. Jacobson K.A., Van Galen P.J.M., Williams M. Adenosine receptors: pharmacology: structure-activity relationships and therapeutic potential. J. Med. Chem. 35:1992;407-422.
22. 2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267:1993;801-808.
23. 3H] Acetylocholine release J. Neurochem. 62:1994;960-966.
24. Kirkpatrick K.A., Richardson P.J. Adenosine receptor mediated modulation of ACh release from rat striatal synaptosomes. Br. J. Pharmacol. 110:1993;949-954.
25. 2A receptor-mediated modulation of striatal GABA and ACh release. Br. J. Pharmacol. 113:1994;43-48.
26. 2 receptor interaction in globus pallidus. Synapse. 22:1996;132-138.
27. 3 receptors regulate serotonin transport via nitric oxide and cGMP. J. Biol. Chem. 269:1994;27351-27356.
28. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience. 67:1995;49-55.
29. Myers S., Pugsley T.A. Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists. Brain Res. 375:1986;193-197.
30. O'Dell S.J., Weihmueller F.B., Marshall J.F. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564:1991;256-260.
31. 2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212:1996;53-56.
32. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, Academic Press, San Diego, 1986.
33. Phillis J.W., Wu P.H. The role of adenosine and its nucleotides in central synaptic transmission. Prog. Neurobiol. 16:1981;187-239.
34. Ricaurte G.A., Guillery R.W., Seiden K.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:1982;93-103.
35. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol. Sci. 13:1992;439-445.
36. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067.
37. Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., Gibb J.W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233:1985;539-544.
38. Seale T.W., Abla K.A., Shamim M.T., Carney J.W., Daly J.W. 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci. 43:1988;1671-1684.
39. 2 receptor-mediated excitatory actions on the nervous system. Prog. Neurobiol. 48:1996;167-189.
40. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 32:1993;639-677.
41. Sonsalla P.K., Giovanni A., Sieber B.A., Delle Donne K.T., Manzino L. Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine. Ann. NY Acad. Sci. 648:1992;229-238.
42. Sonsalla P.K., Jochnowitz N.D., Zecvalk G.D., Oostveen J.A., Hall E.D. Treatment of mice with methamphetamine produces loss in the substantia nigra. Brain Res. 738:1996;172-175.
43. Wagner G.C., Lucot J.B., Schuster C.R., Seiden L.S. Alpha-methyl-tyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res. 270:1983;285-288.
44. M. Williams, Adenosine receptor Agonists and Antagonists, in: T. Stone (Ed.), Adenosine in Nervous System, Academic Press, London, 1991, pp. 137-171.
45. 1 receptor mediation. Neuropharmacology. 28:1989;21-25.